Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Blend · Rbb

Boston Partners Long/Short Research Fund Institutional Class (BPIRX)

Ticker BPIRX · · Holdings as of May 31, 2026

Expense ratio
2.09%$209/yr per $10k
5-yr return
+12.5%annualized
1-yr return
+15.0%as of Dec 2025
Net assets
$588.1Mall share classes
Holdings
422

Bottom line

Is BPIRX a good fund? The bottom line

BPIRX is the Institutional Class share class of Boston Partners Long/Short Research Fund, an actively managed large blend mutual fund from Rbb.

Its expense ratio is 2.09% — about $209 a year on every $10,000 invested, more expensive than 94% of large blend funds we track.

It returned +15.0% over one year, +12.5% a year over five years, +6.6% a year over ten (as of Dec 31, 2025, per its prospectus).

With $588 million in net assets and 422 holdings, its largest position is Flex Ltd (1.9%) and the top 10 make up 12.2% of the portfolio.

What stands out

  • 5-year return beat 71% of category peers
  • Broadly diversified (422 holdings)

What to watch

  • Expensive for its category (2.09%)
  • 12b-1 marketing fee of 0.25% a year

Updated Nov 19, 2026

What BPIRX invests in

The Boston Partners Long/Short Research Fund (the Fund) seeks long-term growth of capital with reduced exposure to general equity market risk.

"The Fund uses a hedged strategy. The Fund actively invests in long positions in stocks identified by the Adviser as undervalued and takes short positions in stocks that the Adviser has identified as overvalued. The cash proceeds from short sales (i.e., sales of securities the Fund does not own) are invested in short-term cash instruments to produce a return on such proceeds just below the federal funds rate. Short sales are considered speculative transactions and a form of leverage. The Fund invests, both long and short, in equity securities issued by large-, mid- and small (or ""micro"") cap companies, as well as other instruments that are convertible into equity securities. Selling securities short is a form of leverage. Equity securities in which the Fund may invest include exchange-traded and over-the-counter common and preferred stocks, warrants, rights, convertible securities…

From the fund's prospectus (filed Jul 2, 2026).

BPIRX performance

Fund calendar-year total returns, 2015–2025 2015: +1.5%; 2016: +3.6%; 2017: +10.1%; 2018: −10.6%; 2019: +12.6%; 2020: −8.3%; 2021: +23.8%; 2022: +6.5%; 2023: +4.7%; 2024: +13.5%; 2025: +15.0% +2% 2015 +4% 2016 +10% 2017 −11% 2018 +13% 2019 −8% 2020 +24% 2021 +6% 2022 +5% 2023 +13% 2024 +15% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
BPIRX+15.0%+12.5%+6.6%
Large Blend median+13.8%+9.7%+10.9%

Source: Fund prospectus, as of Dec 31, 2025

Full BPIRX performance history →

What BPIRX costs

On a $10,000 investment, BPIRX's 2.09% expense ratio costs about $209 a year. The prospectus estimates $21,585 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.

See the full BPIRX fee table →

BPIRX top 10 holdings

#Holding% of fund
1Flex Ltd FLEX1.90%
2Seagate Technology Holdings PL STX1.47%
3Frontdoor Inc FTDR1.40%
4JPMorgan Chase & Co JPM1.27%
5AbbVie Inc ABBV1.09%
6Wells Fargo & Co WFC1.09%
7UnitedHealth Group Inc UNH1.03%
8Broadcom Inc AVGO1.01%
9Bank of America Corp BAC0.97%
10Lam Research Corp LRCX0.96%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 12.2% of the fund. See all top 25 holdings and asset mix →

Alternatives to BPIRX

More funds like BPIRX →

BPIRX FAQ

What is the expense ratio of BPIRX?
BPIRX's expense ratio is 2.09%, which works out to about $209 a year for every $10,000 invested. The prospectus estimates total costs of $21,585 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is BPIRX a good investment?
It depends on your goals, but the data points to: 5-year return beat 71% of category peers; broadly diversified (422 holdings); expensive for its category (2.09%); 12b-1 marketing fee of 0.25% a year. This is general information, not personalized advice.
What does BPIRX hold?
BPIRX's largest holdings are Flex Ltd (1.9%), Seagate Technology Holdings PL (1.5%), Frontdoor Inc (1.4%), JPMorgan Chase & Co (1.3%), AbbVie Inc (1.1%). It holds 422 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is BPIRX's 5-year return?
BPIRX returned +12.5% a year over the five years ending Dec 31, 2025, and +6.6% a year over ten years. Past performance does not guarantee future results.
Who manages BPIRX?
BPIRX is offered by Rbb through Rbb Fund, Inc..